Clinical Trials Browser

Phase 2 × INDUSTRY × entinostat × Clear all

NCT00750698 2023-07-06

A Phase 2 Exploratory Study of Erlotinib and SNDX-275 in Participants With Non-small Cell Lung Carcinoma Who Are Progressing on Erlotinib

Phase 2 Terminated

8 enrolled 6 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00828854 2022-06-30

Study of the Effect of the Addition of SNDX-275 (Entinostat) to Continued Aromatase Inhibitor (AI) Therapy in Postmenopausal Women With ER+ Breast Cancer Whose Disease is Progressing

Phase 2 Completed

27 enrolled 13 charts

Breast Neoplasms

NCT03291886 2022-06-21

Phase 2 Study of KHK2375 in Subjects With Advanced or Recurrent Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT00676663 2022-05-11

ENCORE301

Phase 2 Completed

130 enrolled 18 charts

Breast Neoplasms, Mammary Neoplasms, Animal

NCT00866333 2019-10-22

ENGAGE-501

Phase 2 Terminated

49 enrolled 12 charts

Hodgkin Disease

NCT00185302 2015-12-14

Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Melanoma

Phase 2 Completed

Melanoma

NCT02115594 2014-10-08

ENCORE305

Phase 2 Withdrawn

Breast Neoplasms